Literature DB >> 12635831

Diagnosis of arsenicosis.

Kshitish Chandra Saha1.   

Abstract

Arsenicosis is chronic subclinical or clinical toxicity due to high level of arsenic in body. Diagnosis of arsenicosis was derived by chronological establishment of facts: (a) arsenic as the cause of malady, (b) drinking water (tubewell water) as the vehicle of arsenic, (c) soil as the source of arsenic, (d) mechanism of leaching of arsenic from soil, and (e) cause of prevalence in particular areas of the country. Arsenicosis has been classified by the author into 4 stages, 7 grades and 20 subgrades. Stage I is pre-clinical or grade 0. While clinical features were not found at this stage, high level of arsenic metabolites was observed in urine. As disease progressed to stable phase of grade 0, high level of arsenic was also found in nails, hair, and skin scales. Stage II or clinical stage is divided into 4 grades, (1) Melanosis, (2) Spotted keratosis in palms/soles, (3) Diffuse keratosis in palms/soles, and (4) Dorsal keratosis. Clinical complications are grouped in stage III and grade 5. Malignancy is considered in stage IV and grade 6. There is a concern of both underdiagnosis and overdiagnosis. Therefore, cases of arsenicosis should be cautiously evaluated. Melanosis was the earliest cutaneous sign of clinical arsenicosis. Mild cases of melanosis could only be revealed by a thorough comparison with normal palms. Similarly mild cases of keratosis might not be visible and could only be revealed by careful palpation of palms and soles. Combination of melanosis and keratosis in adults indicated clinical diagnosis of arsenical dermatosis (ASD) that should be confirmed by showing high arsenic concentration in body tissues e.g., nails, hair, skin scales. Isolated melanosis or keratosis in newborn or children below 2 years almost negated the diagnosis of arsenicosis. Genetic melanosis or keratosis is often present since birth. Isolated melanosis or keratosis in adults should be differentiated from non-arsenical dermatosis and proven by absence of high arsenic level in nails and hair. Non arsenical causes of diffuse melanosis, spotted melanosis or leucomelanosis and localized or generalized keratosis can be clinically differentiated from arsenicosis by absence of pigmentation and keratosis in palms/soles.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12635831     DOI: 10.1081/ese-120016893

Source DB:  PubMed          Journal:  J Environ Sci Health A Tox Hazard Subst Environ Eng        ISSN: 1093-4529            Impact factor:   2.269


  12 in total

1.  Arsenic in groundwaters of the Lower Mekong.

Authors:  Gordon Stanger; To Van Truong; K S Le Thi My Ngoc; T V Luyen; Tuyen Tran Thanh
Journal:  Environ Geochem Health       Date:  2005-12       Impact factor: 4.609

2.  Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh.

Authors:  Yu Chen; Faruque Parvez; Mary Gamble; Tariqul Islam; Alauddin Ahmed; Maria Argos; Joseph H Graziano; Habibul Ahsan
Journal:  Toxicol Appl Pharmacol       Date:  2009-01-27       Impact factor: 4.219

3.  Direct analysis and stability of methylated trivalent arsenic metabolites in cells and tissues.

Authors:  Jenna M Currier; Milan Svoboda; Tomáš Matoušek; Jiří Dědina; Miroslav Stýblo
Journal:  Metallomics       Date:  2011-10-21       Impact factor: 4.526

Review 4.  Elemental and chemically specific X-ray fluorescence imaging of biological systems.

Authors:  M Jake Pushie; Ingrid J Pickering; Malgorzata Korbas; Mark J Hackett; Graham N George
Journal:  Chem Rev       Date:  2014-08-07       Impact factor: 60.622

5.  A prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions.

Authors:  Yu Chen; Marni Hall; Joseph H Graziano; Vesna Slavkovich; Alexander van Geen; Faruque Parvez; Habibul Ahsan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-02       Impact factor: 4.254

6.  Arsenic exposure and type 2 diabetes: results from the 2007-2009 Canadian Health Measures Survey.

Authors:  S K Feseke; J St-Laurent; E Anassour-Sidi; P Ayotte; M Bouchard; P Levallois
Journal:  Health Promot Chronic Dis Prev Can       Date:  2015-06       Impact factor: 3.240

Review 7.  Drinking Water Arsenic Contamination, Skin Lesions, and Malignancies: A Systematic Review of the Global Evidence.

Authors:  Margaret R Karagas; Anala Gossai; Brandon Pierce; Habibul Ahsan
Journal:  Curr Environ Health Rep       Date:  2015-03

8.  Arsenic exposure and the induction of human cancers.

Authors:  Victor D Martinez; Emily A Vucic; Daiana D Becker-Santos; Lionel Gil; Wan L Lam
Journal:  J Toxicol       Date:  2011-11-15

9.  Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions.

Authors:  J Richard Pilsner; Xinhua Liu; Habibul Ahsan; Vesna Ilievski; Vesna Slavkovich; Diane Levy; Pam Factor-Litvak; Joseph H Graziano; Mary V Gamble
Journal:  Environ Health Perspect       Date:  2008-09-26       Impact factor: 9.031

10.  Impact of smoking and chewing tobacco on arsenic-induced skin lesions.

Authors:  Anna-Lena Lindberg; Nazmul Sohel; Mahfuzar Rahman; Lars Ake Persson; Marie Vahter
Journal:  Environ Health Perspect       Date:  2009-11-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.